1. Bé M-M, Chisté V, Dulieu C, Mougeot X, Chechev VP, Kuzmenko NK, Kondev FG, Luca A, Galán M, Nichols AL, Arinc A, Pearce A, Huang X. Wang B (2011) Table of Radionuclides (Vol. 6 - A = 22 to 242). Monographie BIPM-5, vol.6., Bureau International des Poids et Mesures
2. National Nuclear Data Center, information extracted from the NuDat 2 database, https://www.nndc.bnl.gov/nudat2/
3. Jalilian A, Osso J Jr (2017) The current status and future of theranostic copper-64 radiopharmaceuticals. Iran J Nucl Med 25:1–10
4. Anderson CJ, Ferdani R (2009) Copper-64 Radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother Radio 24:379–392
5. Wadas TJ, Wong EH, Weisman GR, Anderson CJ (2007) Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr Pharm Des 13:3–16